News

Patients with stage II and IIIB non-small cell lung cancer (NSCLC) with an EGFR mutation had better outcomes when treated ...
This study reveals the potential of engineered phage-IL-12 therapy in melanoma, enhancing immune response and tumor ...
Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...
Researchers at Tel Aviv University's Gray Faculty of Medical & Health Sciences conducted a series of experiments using advanced technologies, focusing on the tumor microenvironment in advanced stages ...
Here are all the ways medical marijuana helps fight cancer. And as science continues to investigate its benefits, evidence ...
In tests with mice, a protein derived from the virus boosted the immune system's ability to kill cancer cells.
A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...
Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...
Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...
Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...